Article
Medicine, General & Internal
Jianmin Zeng, Man Li, Huasheng Shi, Jianhui Guo
Summary: This study revealed that FGD6 was significantly overexpressed in GC tissues and associated with higher histological grade, stage, and poor prognosis. Multivariate Cox regression analysis indicated that FGD6 was an independent prognostic factor for survival in GC patients.
FRONTIERS IN MEDICINE
(2021)
Article
Oncology
Sheng Liu, Xinghua Cao, Shaobin Wu
Summary: The study found that SMARCC1 is frequently upregulated in gastric cancer and is significantly associated with clinical pathological factors such as tumor size, differentiation, depth of invasion, lymph node involvement, and TNM stage. Furthermore, high expression of SMARCC1 predicts poor prognosis in gastric cancer patients and may serve as a prognostic biomarker and therapeutic target in gastric cancer.
AMERICAN JOURNAL OF CANCER RESEARCH
(2022)
Article
Oncology
Hai-Chao Yan, Cheng Xiang
Summary: This study reveals the function and mechanism of BUB1B in thyroid cancer. BUB1B is identified as a promising prognostic factor and a potential therapeutic target for THCA. It is involved in the cell cycle pathway and has significant impacts on tumor cell proliferation, invasion, migration, and apoptosis.
Article
Nutrition & Dietetics
Shanjun Tan, Qiulin Zhuang, Zhige Zhang, Shuhao Li, Jiahao Xu, Junjie Wang, Yanni Zhang, Qiulei Xi, Qingyang Meng, Yi Jiang, Guohao Wu
Summary: This study investigated the link between postoperative loss of skeletal muscle mass and survival following gastric cancer surgery, finding that patients with postoperative skeletal muscle index loss >= 5% had poorer overall survival and disease-free survival. Further research is needed to determine whether stabilizing or enhancing skeletal muscle mass after surgery improves survival outcomes.
FRONTIERS IN NUTRITION
(2022)
Article
Genetics & Heredity
Zhengqi Bao, Ruizhi Zhu, Huagang Fan, Yuchen Ye, Tian Li, Damin Chai
Summary: Overexpression of SPAG6 and low expression of NM23 are negatively related to pathological grade, metastasis, and Enneking stage and prognosis of osteosarcoma patients.
FRONTIERS IN GENETICS
(2022)
Article
Oncology
Minseok Choi, SeongRyeol Moon, Hyo Jin Eom, Seung Mook Lim, Yon Hui Kim, Seungyoon Nam
Summary: PRNP gene may serve as a prognostic factor for gastric cancer patients, with high expression of PRNP being associated with poor survival rates, and knockdown of PRNP reducing cell viability in gastric cancer cells.
Article
Oncology
Peng Xu, Xiaolan Xu, Lixiang Zhang, Zhengnan Li, Jianjun Qiang, Jie Yao, Aman Xu
Summary: The study found that hsa_circ_0060975 expression was significantly elevated in gastric cancer tissues, cell lines, and plasma samples, and was associated with histological grade, pathological stage, and T classification in GC patients. It may serve as an independent prognostic factor for GC patients.
Article
Gastroenterology & Hepatology
Shuaibing Lu, Liangqun Peng, Fei Ma, Junhui Chai, Yawei Hua, Wei Yang, Zhandong Zhang
Summary: This study demonstrated that POSTN is highly expressed in gastric cancer and is associated with poor prognostic features. POSTN may serve as a useful biomarker in predicting survival of gastric cancer patients.
JOURNAL OF GASTROINTESTINAL SURGERY
(2023)
Article
Clinical Neurology
Chang-yi Zhao, Chun-hui Hua, Chang-hua Li, Rui-zhe Zheng, Xin-yuan Li
Summary: This study found that high expression of PYGL is positively associated with glioma malignancy and serves as an independent predictor of poor prognosis in patients with glioma. The study used bioinformatics analysis to identify potential mechanisms underlying the predictive value of PYGL in gliomas, with different gene sets related to signaling pathways and angiogenesis enriched in high PYGL expression phenotype. Single-cell sequencing data analysis further confirmed the high expression of PYGL in specific cell groups, including tumor-associated macrophages and malignant cells.
FRONTIERS IN NEUROLOGY
(2021)
Article
Oncology
Qianna Jin, Qianqian Ren, Xiaona Chang, Haixing Yu, Xin Jin, Xiaoming Lu, Nan He, Guobin Wang
Summary: The study found that NRP1 was highly expressed in gastric cancer tissues and associated with poor prognosis; NRP1 induces EMT to promote the migration and invasion of GC cells by activating PI3K/Akt signaling pathway; NRP1 serves as an independent prognostic marker for OS in GC patients and a potential therapeutic target.
Article
Oncology
Mengjie Wu, Yongfeng Ding, Nan Wu, Junjie Jiang, Yingying Huang, Fanyu Zhang, Haiyong Wang, Quan Zhou, Yan Yang, Wei Zhuo, Lisong Teng
Summary: The role of Follistatin-like protein 1 (FSTL1) in tumorigenesis and cancer progression is conflicting. Nevertheless, this study shows that FSTL1 is frequently upregulated in primary GC tissues and significantly correlated with the progression and poor prognosis of gastric cancer. FSTL1 contributes to GC proliferation, migration, and invasion by regulating the AKT signaling pathway.
AMERICAN JOURNAL OF CANCER RESEARCH
(2021)
Retraction
Biochemistry & Molecular Biology
Mingming Zhang, Pei Liu, Famei Xu, Yuanlong He, Xiangjun Xie, Xiangjun Jiang
Summary: The article on Vinculin promoting gastric cancer proliferation and migration has been retracted due to flaws and inconsistencies, and the conclusions were deemed invalid by the editors.
JOURNAL OF CELLULAR BIOCHEMISTRY
(2021)
Review
Oncology
Chengzhi Wei, Zhu Yu, Gonghe Wang, Yiming Zhou, Lei Tian
Summary: This meta-analysis revealed that low albumin-to-globulin ratio (AGR) is associated with worse overall survival and disease-free survival/progression-free survival in gastric cancer patients, and this association remains consistent across different conditions.
FRONTIERS IN ONCOLOGY
(2021)
Article
Pathology
Hideaki Mita, Hiroto Katoh, Daisuke Komura, Miwako Kakiuchi, Hiroyuki Abe, Hirofumi Rokutan, Koichi Yagi, Sachiyo Nomura, Tetsuo Ushiku, Yasuyuki Seto, Shumpei Ishikawa
Summary: In this study, immunohistochemical analysis of 342 gastric cancer cases revealed that approximately half of the samples showed aberrant expression of CDH11 in gastric cancer cells. The aberrant expression of CDH11 was statistically associated with bone metastasis, as well as liver and distant lymph node metastasis. Therefore, aberrant CDH11 expression in gastric cancer cells can serve as a predictive biomarker for distant metastasis.
PATHOLOGY RESEARCH AND PRACTICE
(2023)
Review
Medicine, General & Internal
Xikai Wang, Qinghe Meng, Yuanyuan Wang, Yanlu Gao
Summary: High expression of MMP14 is associated with shorter overall survival and worse clinicopathological features in patients with gastric cancer. MMP14 could serve as a prognostic factor and potential therapeutic target for gastric cancer. Data from TCGA and GEO further support the association of MMP14 expression with poor prognosis in gastric cancer.
Review
Gastroenterology & Hepatology
Leonard Depotte, Juliette Palle, Cosimo Rasola, Chloe Broudin, Vlad-Adrian Afrasanie, Antoine Mariani, Aziz Zaanan
Summary: Advanced gastric adenocarcinoma is a disease with poor prognosis. In recent years, new drugs, such as trastuzumab for HER2-positive tumors, ramucirumab alone or in combination with paclitaxel, and trifluridine-tipiracil, have improved patient survival. Other drugs, including monoclonal antibodies and targeted therapies, are also being evaluated.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
(2024)